Dihydrofolate reductase mutations in Plasmodium vivax from Indonesia and therapeutic response to sulfadoxine plus pyrimethamine.
BACKGROUND: The target enzyme of pyrimethamine is dihydrofolate reductase (DHFR), but little is known about allelic variants of dhfr in Plasmodium vivax populations. Still less is known about associations between specific alleles and the failure of sulfadoxine/pyrimethamine (S/P) to clear the eryth...
Main Authors: | Hastings, MD, Porter, K, Maguire, J, Susanti, I, Kania, W, Bangs, M, Sibley, C, Baird, J |
---|---|
פורמט: | Journal article |
שפה: | English |
יצא לאור: |
2004
|
פריטים דומים
-
Effects of point mutations in Plasmodium falciparum dihydrofolate reductase and dihydropterate synthase genes on clinical outcomes and in vitro susceptibility to sulfadoxine and pyrimethamine.
מאת: David J Bacon, et al.
יצא לאור: (2009-08-01) -
Molecular monitoring of the Leu-164 mutation of dihydrofolate reductase in a highly sulfadoxine/pyrimethamine-resistant area in Africa.
מאת: Ochong, E, et al.
יצא לאור: (2003) -
Multiple origins of resistance-conferring mutations in <it>Plasmodium vivax dihydrofolate reductase</it>
מאת: O'Neil Michael T, et al.
יצא לאור: (2008-04-01) -
Association of genetic mutations in Plasmodium vivax dhfr with resistance to sulfadoxine-pyrimethamine: geographical and clinical correlates.
מאת: Imwong, M, et al.
יצא לאור: (2001) -
Combined chloroquine, sulfadoxine/pyrimethamine and primaquine against Plasmodium falciparum in Central Java, Indonesia.
מאת: Lederman, E, et al.
יצא לאור: (2006)